Minerva Neurosciences, Inc (NERV) Social Stream



Minerva Neurosciences, Inc (NERV): $7.25

0.60 (-7.64%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add NERV to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#213 of 345

in industry

MINERVA NEUROSCIENCES INC (NERV) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering NERV.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 3 $10 $3 $6.5 $5.02 29.48%
2022-03-04 3 $40 $24 $32 $5.02 537.45%
2022-08-23 2 $24 $24 $24 $5.02 378.09%
2022-10-18 3 $8 $8 $8 $5.02 59.36%
2022-11-10 3 $8 $8 $8 $5.02 59.36%
2023-05-16 2 $8 $8 $8 $5.02 59.36%
2023-11-10 2 $11 $11 $11 $5.02 119.12%

The Trend in the Analyst Price Target


Over the past 28 months, NERV's average price target has gone up $4.

Over the past 35 weeks, NERV's average upside potential has been 139.17%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-09 2 8 8 8 1.81 341.99%
2023-05-16 2 8 8 8 5.64 41.84%
2023-08-02 2 11 11 11 10.52 4.56%
2023-11-10 2 11 11 11 4.10 168.29%

NERV Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3 0 0 2 0 0 2

The Trend in the Broker Recommendations


Over the past 43 months, NERV's average broker recommendation rating worsened by 1.67.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for NERV as an investment opportunity.

  • In terms of how MINERVA NEUROSCIENCES INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 49.48% of that group.
  • In terms of how MINERVA NEUROSCIENCES INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -109.65% of that group.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, MINERVA NEUROSCIENCES INC's average analyst price target is greater than 374.98% of them.
  • MINERVA NEUROSCIENCES INC's upside potential (average analyst target price relative to current price) is greater than 467.82% of stocks in the small market cap category.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to MINERVA NEUROSCIENCES INC are EGRX, ELDN, and ARDX.

Is NERV a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!